Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT00057720
Eligibility Criteria:
Inclusion criteria include:
* Considered platinum refractory or resistant according to standard criteria
* Progressed during or following completion of one second-line treatment with Doxil/Caelyx or Hycamtin
* Histologically or cytologically confirmed diagnosis of epithelial cancer of the ovary, fallopian tube, or primary peritoneal cancer
* Measurable disease according to RECIST criteria with documented tumor progression
Exclusion criteria include:
* Treatment with second-line chemotherapy other than Doxil/Caelyx or Hycamtin
* History of whole pelvis radiation therapy within 12 months of enrollment
* Clinically significant cardiac disease
* Evidence of gross hematuria at the time of study entry
* Any signs of intestinal obstruction interfering with nutrition at the time of study entry
* Pregnant or lactating women
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00057720
Study Brief:
Protocol Section:
NCT00057720